Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DOPA-PET for Radiotherapy Planning in Newly Diagnosed Gliomas
NCT01991977Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2013
- Primary completion
- Jul 2019
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of Fluorodopa F 18 in malignant glioma, sponsored by Mayo Clinic. Started Dec 2013; status: completed.
02
Drugs
Fluorodopa F 18
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01991977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01991977.